MONIKA BUDHATHOKI: Open Payments
NPI 1588038889 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,310 in 68 payments from 15 companies in 2025. Trend: 2023 $1,008 · 2024 $1,309 · 2025 $1,310
Food & beverage: $1,210Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $510 |
| Janssen Biotech, Inc. | 7 | $205 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $192 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $86 |
| Regeneron Healthcare Solutions, Inc. | 3 | $62 |
| Phathom Pharmaceuticals, Inc. | 3 | $57 |
| Astellas Pharma US Inc | 1 | $34 |
| QOL Medical, LLC | 1 | $31 |
| Ipsen Biopharmaceuticals, Inc | 1 | $27 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $20 |
Products named: RINVOQ, TREMFYA, ENTYVIO, LINZESS, XIFAXAN, SKYRIZI, DUPIXENT, VOQUEZNA.
Industry payments across TX — which companies pay providers there.
